Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea

被引:3
|
作者
Kwon, Yu-Jin [1 ]
Choi, Ja-Eun [2 ]
Hong, Kyung-Won [2 ]
Lee, Ji-Won [3 ,4 ]
机构
[1] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Family Med, 363 Dongbaekjukjeon Daero, Yongin 16995, Gyeonggido, South Korea
[2] Theragen Hlth Co Ltd, Inst Adv Technol, Pangyoyeok Ro, Seongnam 13493, Gyeonggido, South Korea
[3] Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Yonsei Ro 50-1, Seoul 03722, South Korea
[4] Yonsei Univ, Inst Innovat Digital Healthcare, Yonsei Ro 50-1, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
Mediterranean diet; Metabolic dysfunction-associated fatty liver disease; Gene-diet interaction; Glucokinase regulatory protein gene; FATTY LIVER; TRIGLYCERIDE; VALIDATION; OBESITY; LOCI; GCKR;
D O I
10.1186/s12967-024-05408-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Backgrounds Metabolic dysfunction-associated steatotic liver disease (MASLD) has gained attention owing to its severe complications. This study aimed to explore the interaction between Mediterranean-diet (MD) adherence, genetic factors, and MASLD risk in a Korean population. Methods In total, 33,133 individuals aged 40 years and older from the Korean Genome and Epidemiology Study (KoGES) were analyzed. Participants were assessed for MASLD based on criteria and MD adherence measured by the Korean version of the Mediterranean-Diet Adherence Screener (K-MEDAS). Individuals were categorized into two groups based on their MD adherence: high adherence (K-MEDAS > 6) and low adherence (K-MEDAS < 5). Single nucleotide polymorphism (SNP) genotypes were obtained using the Korea Biobank array. Logistic regression was used to examine the single-marker variants for genetic associations with MASLD prevalence. Results Individuals were categorized into MASLD (10,018 [30.2%]) and non-MASLD (23,115 [69.8%]) groups. A significant interaction was observed between the rs780094 glucokinase regulatory protein (GCKR) gene and K-MEDAS on MASLD (p < 10(-2)). Of individuals with K-MEDAS > 6, those carrying the minor allele (C) of the GCKR gene rs780094 exhibited a lower risk of MASLD compared to those without the allele (odds ratio [OR] = 0.88 [0.85-0.91], p-value = 5.54e-13). Conclusion The study identified a significant interaction involving the rs780094 variant near the GCKR gene, with carriers of the minor allele exhibiting a lower MASLD risk among those adhering well to the MD. Dietary habits influence the MASLD risk associated with the rs780094 allele, emphasizing the need for personalized nutrition recommendations.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Pei, Yiying
    Goh, George Boon-Bee
    GUT AND LIVER, 2025, 19 (01) : 8 - 18
  • [2] Metabolic dysfunction-associated steatotic liver disease (MASLD): Assessing cardiovascular risk factors and the impact of mediterranean diet
    Awada, E.
    Abdallah, H.
    Shanmugam, H.
    Abele, R.
    Di Ciaula, A.
    Krawczyk, M.
    Portincasa, P.
    Khalil, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54
  • [3] Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis
    Lee, Ji Yae
    Kim, Sue
    Lee, Yaeji
    Kwon, Yu-Jin
    Lee, Ji-Won
    NUTRIENTS, 2024, 16 (20)
  • [4] Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
    Plaza-Aulestia, Nahia
    Ibarguengoitia-Barrena, Oihane
    Sampedro-Andrada, Blanca
    Juan-Lopez, Cristina San
    Morillo-Montanes, Victoria
    Urionaguena, Irati
    Calvo, Itziar
    Seisdedos, David Montero
    Vega-Alvarez, Lucia
    Llorente, Jose Francisco Garcia
    Revenga, Nuria Vegas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4669 - 4671
  • [5] Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver disease
    Kaplan, David E.
    Teerlink, Craig C.
    Schwantes-An, Tae-Hwi
    Norden-Krichmar, Trina M.
    DuVall, Scott L.
    Morgan, Timothy R.
    Tsao, Philip S.
    Voight, Benjamin F.
    Lynch, Julie A.
    Vujkovic, Marijana
    Chang, Kyong-Mi
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (07)
  • [6] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [7] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [8] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [9] Identification of Risk Factors Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Psoriatic Patients
    Kucuk, Kirley
    Moreno, Christophe
    Nijmi, Hassane
    Daoud, Mathieu
    Mintoff, Dillon
    Willaert, Fabienne
    Benhadou, Farida
    DERMATOLOGY, 2025, 241 (01)
  • [10] Risk factors for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
    Liew, Ian Yang
    Phua, Hwee Pin
    Lim, Wei Yen
    Chow, Angela
    Loo, Xiu Ying
    Sim, Kevin
    Lee, Eng Sing
    Yew, Kuo Chao
    JOURNAL OF HEPATOLOGY, 2024, 80 : S497 - S498